表紙
市場調査レポート

卵巣疾患:世界の治験レビュー

Ovarian Disease Global Clinical Trials Review, H2, 2015

発行 GlobalData 商品コード 226831
出版日 ページ情報 英文 128 Pages
即納可能
価格
本日の銀行送金レート: 1USD=102.85円で換算しております。
Back to Top
卵巣疾患:世界の治験レビュー Ovarian Disease Global Clinical Trials Review, H2, 2015
出版日: 2015年12月04日 ページ情報: 英文 128 Pages
概要

当レポートでは、卵巣疾患に関する治験動向について、 治験数および被験者数、段階別・相別の状況、有望企業、開発中の治療薬情報、 治験のプロファイルなどをまとめ、概略以下の構成でお届けします。

目次

  • イントロダクション
    • 卵巣疾患
    • レポートガイダンス
  • 臨床試験:地域別
  • 臨床試験:国別
    • 臨床試験に寄与している上位国 − アジア太平洋地域
    • 臨床試験に寄与している上位5ヵ国 − 欧州
    • 臨床試験に寄与している上位国 − 北米
    • 臨床試験に寄与している上位5ヵ国 − 中東およびアフリカ
  • 臨床試験:BRIC 諸国
  • 臨床試験:G7 諸国
  • 臨床試験:G7 諸国 治験ステータス別
  • 臨床試験:E7 諸国
  • 臨床試験:E7 諸国 治験ステータス別
  • 臨床試験:相別
    • 進行中の治験:相別
  • 臨床試験:治験ステータス別
  • 未完了の治験
  • 期間ごとの被験者数
  • 有力なスポンサー
    • 治験参加上位企業
  • 有望な治療薬 比較
  • 臨床試験プロファイル
    • 臨床試験概要: 上位企業
      • Organon USA Inc.
      • Merck & Co., Inc.
      • Ferring Pharmaceuticals
      • Eugonia
      • Omrix Biopharmaceuticals, Inc.
    • 臨床試験概要: トップレベルの大学 / 研究機関 / 病院
      • Instituto Valenciano de Infertilidad
      • Children's Memorial Hospital
      • Nemours Children's Clinic
      • Virginia Center for Reproductive Medicine
      • King's College London
      • Yale University
      • Cairo University
      • University of Connecticut Health Center
      • Shahid Beheshti University
      • Royan Institute
      • University of Schleswig-Holstein
      • Columbia University
      • The University of Edinburgh
      • Tabriz University
      • UMC Utrecht
      • Stanford University
      • Centers for Disease Control and Prevention
      • Norwegian University of Science and Technology
      • Maastricht University Medical Center
      • Assistance Publique - Hopitaux de Paris
  • 5件の重要臨床プロファイル

付録

図表一覧


このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: GDHC3033CTIDB

GlobalData's clinical trial report, "Ovarian Disease Global Clinical Trials Review, H2, 2015" provides an overview of Ovarian Disease clinical trials scenario. This report provides top line data relating to the clinical trials on Ovarian Disease. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Reasons to buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Five Countries Contributing to Clinical Trials in Middle East and Africa
      • Top Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Ovarian Disease to Women's Health Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Ovarian Disease to Women's Health Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Ovarian Disease Therapeutics Clinical Trials
  • Prominent Drugs
  • Clinical Trial Profile Snapshots
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Ovarian Disease Therapeutics, Global, Clinical Trials by Region, 2015*
  • Ovarian Disease Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015*
  • Ovarian Disease Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015*
  • Ovarian Disease Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015*
  • Ovarian Disease Therapeutics Clinical Trials, Europe, Top Five Countries, 2015*
  • Ovarian Disease Therapeutics Clinical Trials, North America, Top Countries, 2015*
  • Ovarian Disease Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2015*
  • Ovarian Disease Therapeutics Clinical Trials, Central and South America, Top Countries, 2015*
  • Proportion of Ovarian Disease to Women's Health Clinical Trials, G7 Countries (%), 2015*
  • Ovarian Disease Therapeutics, G7 Countries, Clinical Trials by Phase, 2015*
  • Ovarian Disease Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015*
  • Proportion of Ovarian Disease to Women's Health Clinical Trials, E7 Countries (%), 2015*
  • Ovarian Disease Therapeutics, E7 Countries, Clinical Trials by Phase, 2015*
  • Ovarian Disease Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015*
  • Ovarian Disease Therapeutics, Global, Clinical Trials by Phase, 2015*
  • Ovarian Disease Therapeutics, Global, Clinical Trials In Progress by Phase 2015*
  • Ovarian Disease Therapeutics, Global, Clinical Trials by Trial Status, 2015*
  • Ovarian Disease Therapeutics Clinical Trials, Global, by End Point Status, 2015*
  • Ovarian Disease Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014
  • Ovarian Disease Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015*
  • Ovarian Disease Therapeutics Clinical Trials, Global, Key Sponsors, 2015*
  • Ovarian Disease Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015*
  • Ovarian Disease Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015*

List of Figures

  • Ovarian Disease Therapeutics, Global, Clinical Trials by Region (%), 2015*
  • Ovarian Disease Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015*
  • Ovarian Disease Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015*
  • Ovarian Disease Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015*
  • Ovarian Disease Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015*
  • Ovarian Disease Therapeutics Clinical Trials, North America, Top Countries (%), 2015*
  • Ovarian Disease Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2015*
  • Proportion of Ovarian Disease to Women's Health Clinical Trials, G7 Countries (%), 2015*
  • Ovarian Disease Therapeutics, G7 Countries, Clinical Trials by Phase, 2015*
  • Ovarian Disease Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015*
  • Proportion of Ovarian Disease to Women's Health Clinical Trials, E7 Countries (%), 2015*
  • Ovarian Disease Therapeutics, E7 Countries, Clinical Trials by Phase, 2015*
  • Ovarian Disease Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015*
  • Ovarian Disease Therapeutics, Global, Clinical Trials by Phase (%), 2015*
  • Ovarian Disease Therapeutics, Global, Clinical Trials In Progress by Phase, 2015*
  • Ovarian Disease Therapeutics, Global, Clinical Trials by Trial Status, 2015*
  • Ovarian Disease Therapeutics Clinical Trials, Global, by End Point Status, 2015*
  • Ovarian Disease Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014
  • Ovarian Disease Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015*
  • Ovarian Disease Therapeutics Clinical Trials, Global, Key Sponsors, 2015*
  • Ovarian Disease Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015*
  • Ovarian Disease Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015*
  • GlobalData Methodology
Back to Top